The landscape of pediatric healthcare in the United States is at a pivotal moment as health plans increasingly acknowledge the importance of genomic testing. This shift is leading to expanded policies and improved coverage, which is crucial for families dealing with complex and often unexplained medical conditions. The recognition of the clinical and economic benefits of genomic testing marks significant progress, offering hope and potentially better outcomes for affected families. As coverage improves, more families can access these vital tests, which can provide critical insights into their children’s health issues.
QUESTION: How might the increased availability of genomic testing change the future of healthcare for children with rare or unexplained conditions?
Close the gap in pediatric genomic care
